From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence

• A. Zygogianni ^[1] ; M. Protopapa ^[1] ; A. Kougioumtzopoulou ^[2] ; F. Simopoulou ^[1] ; S. Nikoloudi ^[1] ; V. Kouloulias ^[2]
  1. [1] Aretaieion University Hospital. Athens, Greece
  2. [2] ATTIKON University Hospital. Chaidari, Greece
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 20, Nº. 8, 2018, págs. 989-1003
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • GBM is one of the most common and aggressive brain tumors. Surgery and adjuvant chemoradiation have succeeded in providing a survival benefit. Although most patients will eventually experience local recurrence, the means to fight recurrence are limited and prognosis remains poor. In a disease where local control remains the major challenge, few trials have addressed the efficacy of local treatments, either surgery or radiation therapy. The present article reviews recent advances in the biology, imaging and biomarker science of GBM as well as the current treatment status of GBM, providing new perspectives to the problem of local recurrence.